Diana Wright
Nurse Practitioner · Jackson, OHNPI 1295971661
Payments from drug & device makers
Across 169 payments — averaging $15.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$826
- Novo Nordisk$472
- Amgen$273
- AstraZeneca$150
- Abbott$133
- Journey Medical Corporation$125
- plus $696 from 15 others
What the payments were for
- Food & beverage$2,674100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 61 | $826 |
| Novo Nordisk | 34 | $472 |
| Amgen | 15 | $273 |
| AstraZeneca | 10 | $150 |
| Abbott | 6 | $133 |
| Journey Medical Corporation | 1 | $125 |
| Lilly USA, LLC | 8 | $116 |
| Exact Sciences | 6 | $104 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $103 |
| Bayer | 4 | $90 |
| Dexcom, Inc. | 3 | $49 |
| Pfizer | 3 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| GSK | 2 | $28 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Merck | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
How this compares
$2,674 in reported general payments places this provider in the 90th percentile of 4,700 nurse practitioner providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 62 | $101,203 |
| EliquisApixaban | 108 | $90,456 |
| JanuviaSitagliptin Phosphate | 46 | $38,033 |
| JardianceEmpagliflozin | 36 | $28,845 |
| TrulicityDulaglutide | 24 | $27,490 |
| XareltoRivaroxaban | 14 | $22,552 |
| MounjaroTirzepatide | 11 | $18,080 |
| Spiriva RespimatTiotropium Bromide | 26 | $17,263 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 85 | $14,818 |
| Breo ElliptaFluticasone/Vilanterol | 28 | $12,198 |
| FarxigaDapagliflozin Propanediol | 14 | $12,126 |
| Tresiba Flextouch U-100Insulin Degludec | 11 | $10,895 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $7,520 |
| InvokanaCanagliflozin | 11 | $7,057 |
| LevemirInsulin Detemir | 16 | $6,039 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Levemir | $472 | $107,24278 claims |
| PfizerEliquis | $40 | $90,456108 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $116 | $45,57035 claims |
| MerckJanuvia | $23 | $38,03346 claims |
| GSKBreo Ellipta, Trelegy Ellipta, Incruse Ellipta | $28 | $24,68354 claims |
| AstraZenecaFarxiga | $150 | $12,12614 claims |
| AbbVieSynthroid | $826 | $1,34126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,700 nurse practitioner providers in Ohio.
Other nurse practitioner in Jackson
- Margaret BobonichCleveland$235K
- Mary GallagherWestlake$229K
- Sonia HissettCincinnati$179K
- Ashley TaylorNew Albany$107K
- Beth FaimanCleveland$101K
- Katherine AlexanderColumbus$99K
- Tiffany JonesCincinnati$99K
- Kate NewmanWestlake$78K
- Daniella GerySouth Euclid$73K
- Amy HazelCanton$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.